|
1
|
Deng X, Cao Y, Liu Y, Li F, et al:
Overexpression of Evi-1 oncoprotein represses TGF-β signaling in
colorectal cancer. Mol Carcinog. 52:255–264. 2013.PubMed/NCBI
|
|
2
|
Potter JD: Colorectal cancer: molecules
and populations. J Natl Cancer Inst. 91:916–932. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Domínguez-Ayala M, Díez-Vallejo J and
Comas-Fuentes A: Missed opportunities in early diagnosis of
symptomatic colorectal cancer. Rev Esp Enferm Dig. 104:343–349.
2012.PubMed/NCBI
|
|
4
|
Fearon ER: Molecular genetics of
colorectal cancer. Annu Rev Pathol. 6:479–507. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chan EC, Barry MJ, Vernon SW and Ahn C:
Brief report: physicians and their personal prostate
cancer-screening practices with prostate-specific antigen. A
national survey. J Gen Intern Med. 21:257–259. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Simoglou C, Gymnopoulou E, Simoglou L,
Gymnopoulou M, Nikolaou K and Gymnopoulos D: Surgery for colorectal
cancer in the small town of Komotini. J Multidiscip Healthc.
5:273–276. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kotzev I, Mirchev M, Manevska B, Ivanova I
and Kaneva M: Risk and protective factors for development of
colorectal polyps and cancer (Bulgarian experience).
Hepatogastroenterology. 55:381–387. 2008.PubMed/NCBI
|
|
8
|
Posner MR: Paradigm shift in the treatment
of head and neck cancer: the role of neoadjuvant chemotherapy.
Oncologist. 10(Suppl 3): S11–S19. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Fritz G, Mittl PR, Vasak M, Grutter MG and
Heizmann CW: The crystal structure of metal-free human EF-hand
protein S100A3 at 1.7-A resolution. J Biol Chem. 277:33092–33098.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kizawa K, Takahara H, Unno M and Heizmann
CW: S100 and S100 fused-type protein families in epidermal
maturation with special focus on S100A3 in mammalian hair cuticles.
Biochimie. 93:2038–2047. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kizawa K, Inoue T, Yamaguchi M, Kleinert
P, Troxler H, Heizmann CW and Iwamoto Y: Dissimilar effect of
perming and bleaching treatments on cuticles: advanced hair damage
model based on elution and oxidation of S100A3 protein. J Cosmet
Sci. 56:219–226. 2005.PubMed/NCBI
|
|
12
|
Kizawa K, Unno M, Takahara H and Heizmann
CW: Purification and characterization of the human cysteine-rich
S100A3 protein and its pseudo citrullinated forms expressed in
insect cells. Methods Mol Biol. 963:73–86. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kizawa K, Jinbo Y, Inoue T, Takahara H,
Unno M, Heizmann CW and Izumi Y: Human S100A3 tetramerization
propagates Ca2+/Zn2+ binding states. Biochim
Biophys Acta. 1833:1712–1719. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
van Hazel GA, Pavlakis N, Goldstein D,
Olver IN, Tapner MJ, Price D, Bower GD, Briggs GM, Rossleigh MA,
Taylor DJ and George J: Treatment of fluorouracil-refractory
patients with liver metastases from colorectal cancer by using
yttrium-90 resin microspheres plus concomitant systemic irinotecan
chemotherapy. J Clin Oncol. 27:4089–4095. 2009.
|
|
15
|
Gerber DE: Targeted therapies: a new
generation of cancer treatments. Am Fam Physician. 77:311–319.
2008.PubMed/NCBI
|
|
16
|
Dehmer GJ, Douglas JS Jr, Abizaid A, Berg
JW, Day J, Hall R, Leon MB, Hijazi ZM, Marchlinski F, Park SJ and
Popma JJ: SCAI/ACCF/HRS/ESC/SOLACI/APSIC statement on the use of
live case demonstrations at cardiology meetings: assessments of the
past and standards for the future. Heart Rhythm. 7:1522–1535. 2010.
View Article : Google Scholar
|
|
17
|
Liu HG and Huang HX: Overview
pharmacokinetic about traditional Chinese medicine in recent 10
years. Zhongguo Zhong Yao Za Zhi. 32:2346–2348. 2007.(In
Chinese).
|
|
18
|
Honkanen RE: Cantharidin, another natural
toxin that inhibits the activity of serine/threonine protein
phosphatases types 1 and 2A. FEBS Letters. 330:283–286. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Deng LP, Dong J, Cai H and Wang W:
Cantharidin as an antitumor agent: a retrospective review. Curr Med
Chem. 20:159–166. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Huang YP, Ni CH, Lu CC, Chiang JH, Yang
JS, Ko YC, Lin JP, Kuo JH, Chang SJ and Chung JG: Suppressions of
migration and invasion by cantharidin in TSGH-8301 human bladder
carcinoma cells through the inhibitions of matrix
metalloproteinase-2/−9 signaling. Evid Based Complement Alternat
Med. 2013:1902812013.PubMed/NCBI
|
|
21
|
Zhan YP, Huang XE, Cao J, Lu YY, Wu XY,
Liu J, Xu X, Xu L, Xiang J and Ye LH: Clinical study on safety and
efficacy of Qinin® (cantharidin sodium) injection combined with
chemotherapy in treating patients with gastric cancer. Asian Pac J
Cancer Prev. 13:4773–4776. 2012.PubMed/NCBI
|
|
22
|
Kim YM, Ku MJ, Son YJ, Yun JM, Kim SH and
Lee SY: Anti-metastatic effect of cantharidin in A549 human lung
cancer cells. Arch Pharm Res. 36:479–484. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yeh CH, Yang YY, Huang YF, Chow KC and
Chen MF: Induction of apoptosis in human Hep3B hepatoma cells by
norcantharidin through a p53 independent pathway via TRAIL/DR5
signal transduction. Chin J Integr Med. 18:676–682. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Haggar FA and Boushey RP: Colorectal
cancer epidemiology: incidence, mortality, survival, and risk
factors. Clin Colon Rectal Surg. 22:191–197. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
BenZion I and Helveston EM: Use of
telemedicine to assist ophthalmologists in developing countries for
the diagnosis and management of four categories of ophthalmic
pathology. Clin Ophthalmol. 1:489–495. 2007.PubMed/NCBI
|
|
26
|
Gerber DE: Targeted therapies: a new
generation of cancer treatments. Am Fam Physician. 77:311–319.
2008.PubMed/NCBI
|
